Publication | Open Access

Nifedipine controlled-release 40 mg b.i.d. in Japanese patients with essential hypertension who responded insufficiently to nifedipine controlled-release 40 mg q.d.: a phase III, randomized, double-blind and parallel-group study

Nifedipine Controlled-release 40HypertensionNon-pharmacological InterventionCardiovascular DiseaseMg B.i.dAntihypertensive TherapyControlled-release 40PharmacotherapyMedicineBlood PressureAnesthesiologyEndocrine Hypertension